Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorPedro-Botet, J. (Juan)-
dc.creatorAscaso, F.J. (Francisco J.)-
dc.creatorBarrios, V. (V.)-
dc.creatorSierra, A. (Alejandro)-
dc.creatorEscalada, J. (Javier)-
dc.creatorMillán, J. (Jesús)-
dc.creatorMostaza, J.M. (José M.)-
dc.creatorPérez-Martínez, P. (Pablo)-
dc.creatorPinto, X. (Xavier)-
dc.creatorSalas-Salvado, J. (Jordi)-
dc.creatorValdivielso, P. (Pedro)-
dc.date.accessioned2023-03-30T10:31:40Z-
dc.date.available2023-03-30T10:31:40Z-
dc.date.issued2018-
dc.identifier.citationPedro-Botet, J. (Juan); Ascaso, F.J. (Francisco J.); Barrios, V. (V.); et al. "COSMIC project: consensus on the objectives of the metabolic syndrome in clinic". International journal of literature and arts. 6 (4), 2018, 68 - 76es
dc.identifier.issn1178-7007-
dc.identifier.urihttps://hdl.handle.net/10171/65818-
dc.description.abstractMetabolic syndrome (MetS), a disorder with a high and growing prevalence, is a recognized risk factor for cardiovascular disease (CVD) and type 2 diabetes. It is a constellation of clinical and metabolic risk factors that include abdominal obesity, dyslipidemia, glucose intolerance, and hypertension. Unfortunately, MetS is typically underrecognized, and there is great heterogeneity in its management, which can hamper clinical decision-making and be a barrier to achieving the therapeutic goals of CVD and diabetes prevention. Although no single treatment for MetS as a whole currently exists, management should be targeted at treating the conditions contributing to it and possibly reversing the risk factors. All this justifies the need to develop recommendations that adapt existing knowledge to clinical practice in our healthcare system. In this regard, professionals from different scientific societies who are involved in the management of the different MetS components reviewed the available scientific evidence focused basically on therapeutic aspects of MetS and developed a consensus document to establish recommendations on therapeutic goals that facilitate their homogenization in clinical decision-making.es_ES
dc.language.isoenges_ES
dc.publisherTaylor and Francis Groupes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectCardiovascular preventiones_ES
dc.subjectDiabetes preventiones_ES
dc.subjectInsulin resistancees_ES
dc.subjectHypertensiones_ES
dc.subjectDyslipidemiaes_ES
dc.subjectObesityes_ES
dc.titleCOSMIC project: consensus on the objectives of the metabolic syndrome in clinices_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.description.noteThis work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).es_ES
dc.identifier.doi10.11648/j.ijla.20180604.12-
dadun.citation.endingPage76es_ES
dadun.citation.number4es_ES
dadun.citation.publicationNameInternational journal of literature and artses_ES
dadun.citation.startingPage68es_ES
dadun.citation.volume6es_ES

Ficheros en este ítem:
Vista previa
Fichero
dmso-165740-cosmic-project-consensus-of-the-objectives-of-the-metabolic-103018.pdf
Descripción
Tamaño
1.16 MB
Formato
Adobe PDF


Estadísticas e impacto
0 citas en
0 citas en

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.